Literature DB >> 6166566

Protection of mice against mouse hepatitis virus by Corynebacterium parvum.

L Schindler, G Streissle, H Kirchner.   

Abstract

C57BL/6 mice that are highly susceptible to infection with mouse hepatitis virus type 3 were protected against intraperitoneal viral infection by simultaneous intraperitoneal injection of Corynebacterium parvum. No protection was observed when C. parvum was given intravenously or when it was injected intraperitoneally 3 days before viral infection. Protective effects were, however, consistently found when C. parvum was given 2 h before or 2 h after viral infection. Activity was seen only against 10 50% lethal doses and not against 100 50% lethal doses. C. parvum also caused a significant decrease of virus type 3. These data suggest a direct effect of C. parvum on virus-susceptible cells. Injection of C. parvum in mice caused activation of natural killer (NK) cells and of interferon production. However, these two effects were equally demonstrable at high and low doses of C. parvum, whereas protection against mouse hepatitis virus type 3 was not demonstrable at low doses of C. parvum. Thus, antiviral protection may be dissociated from activation of NK cells and induction of interferon.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6166566      PMCID: PMC351569          DOI: 10.1128/iai.32.3.1128-1131.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  Immunomodulator-induced resistance against herpes simplex virus.

Authors:  P S Morahan; E R Kern; L A Glasgow
Journal:  Proc Soc Exp Biol Med       Date:  1977-04

2.  Induction of interferon production in mouse spleen cell cultures by corynebacterium parvum.

Authors:  H M Hirt; H Becker; H Kirchner
Journal:  Cell Immunol       Date:  1978-06       Impact factor: 4.868

3.  Protection of mice against viral infection by Corynebacterium parvum and Bordetella pertussis.

Authors:  H Kirchner; M T Scott; H M Hirt; K Munk
Journal:  J Gen Virol       Date:  1978-10       Impact factor: 3.891

4.  Suppression of natural killer cell cytotoxicity by splenocytes from Corynebacterium parvum-injected, bone marrow-tolerant, and infant mice.

Authors:  C A Savary; E Lotzová
Journal:  J Immunol       Date:  1978-01       Impact factor: 5.422

5.  Immunological studies of hsv-infection of resistant and susceptible inbred strains of mice.

Authors:  H Kirschner; M Kochen; H M Hirt; K Munk
Journal:  Z Immunitatsforsch Immunobiol       Date:  1978-03

Review 6.  Corynebacterium parvum as an immunotherapeutic anticancer agent.

Authors:  M T Scott
Journal:  Semin Oncol       Date:  1974-12       Impact factor: 4.929

7.  Splenic suppressor macrophages induced in mice by injection of Corynebacterium parvum.

Authors:  H Kirchner; H T Holden
Journal:  J Immunol       Date:  1975-11       Impact factor: 5.422

8.  Natural cell-mediated cytotoxicity in rats. II. In vivo augmentation of NK-cell activity.

Authors:  J R Oehler; L R Lindsay; M E Nunn; H T Holden; R B Herberman
Journal:  Int J Cancer       Date:  1978-02-15       Impact factor: 7.396

9.  Protection against herpes simplex virus infection in mice by Corynebacterium parvum.

Authors:  H Kirchner; H M Hirt; K Munk
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

10.  Immunomodulation of host resistance to experimental viral infections in mice: effects of Corynebacterium acnes, Corynebacterium parvum, and Bacille calmette-guérin.

Authors:  L A Glasgow; J Fischbach; S M Bryant; E R Kern
Journal:  J Infect Dis       Date:  1977-05       Impact factor: 5.226

View more
  7 in total

1.  Activation of natural killer cells and induction of interferon after injection of mouse hepatitis virus type 3 in mice.

Authors:  L Schindler; H Engler; H Kirchner
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

2.  Immune memory: an evolutionary perspective.

Authors:  Beniamino Palmieri; Maria Vadala'; Lucia Palmieri
Journal:  Hum Vaccin Immunother       Date:  2021-01-12       Impact factor: 3.452

3.  A major role of macrophage activation by interferon-gamma during mouse hepatitis virus type 3 infection. I. Genetically dependent resistance.

Authors:  M A Lucchiari; C A Pereira
Journal:  Immunobiology       Date:  1989-11       Impact factor: 3.144

4.  A major role of macrophage activation by interferon-gamma during mouse hepatitis virus type 3 infection. II. Age-dependent resistance.

Authors:  M A Lucchiari; C A Pereira
Journal:  Immunobiology       Date:  1990-08       Impact factor: 3.144

5.  COVID-19 vaccine and boosted immunity: Nothing ad interim to do?

Authors:  Luca Roncati; Maria Vadalà; Veronica Corazzari; Beniamino Palmieri
Journal:  Vaccine       Date:  2020-10-09       Impact factor: 3.641

Review 6.  The long-standing history of Corynebacterium parvum, immunity, and viruses.

Authors:  Beniamino Palmieri; Maria Vadalà; Luca Roncati; Andrea Garelli; Francesco Scandone; Moreno Bondi; Claudio Cermelli
Journal:  J Med Virol       Date:  2020-06-29       Impact factor: 20.693

7.  Protection of mice against infection with mouse hepatitis virus type 3 by injection of silica.

Authors:  L Schindler; J Brücher; H Kirchner
Journal:  Immunobiology       Date:  1984-01       Impact factor: 3.144

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.